494 related articles for article (PubMed ID: 26100991)
81. [Analysis of bone marrow and peripheral blood cytologic features in hyperleukocytic acute leukemia].
Liu YL; Liu HB; Wang WJ; Ma L; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):562-6. PubMed ID: 23815898
[TBL] [Abstract][Full Text] [Related]
82. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia.
Pui CH; Hancock ML; Head DR; Rivera GK; Look AT; Sandlund JT; Behm FG
Blood; 1993 Aug; 82(3):889-94. PubMed ID: 7687897
[TBL] [Abstract][Full Text] [Related]
83. Characterization of Immunophenotypic Aberrancies in Adult and Childhood Acute Lymphoblastic Leukemia: Lessons from Regional Variation.
Rezaei MS; Esfandiari N; Refoua S; Shamaei M
Iran J Pathol; 2020; 15(1):1-7. PubMed ID: 32095142
[TBL] [Abstract][Full Text] [Related]
84. CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies.
Boccuni P; Di Noto R; Lo Pardo C; Villa MR; Ferrara F; Rotoli B; Del Vecchio L
Tissue Antigens; 1998 Jul; 52(1):1-8. PubMed ID: 9714468
[TBL] [Abstract][Full Text] [Related]
85. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.
Uckun FM; Jaszcz W; Chandan-Langlie M; Waddick KG; Gajl-Peczalska K; Song CW
J Clin Invest; 1993 Mar; 91(3):1044-51. PubMed ID: 8450034
[TBL] [Abstract][Full Text] [Related]
86. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
[TBL] [Abstract][Full Text] [Related]
87. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
88. Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens.
Al Gwaiz LA; Bassioni W
Histol Histopathol; 2008 Oct; 23(10):1223-8. PubMed ID: 18712674
[TBL] [Abstract][Full Text] [Related]
89. CD34 is not Expressed by Blasts in a Third of B-ALL Patients and its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis.
Garg N; Gupta R; Kotru M
Asian Pac J Cancer Prev; 2021 Mar; 22(3):919-925. PubMed ID: 33773558
[TBL] [Abstract][Full Text] [Related]
90. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.
Borowitz MJ; Shuster J; Carroll AJ; Nash M; Look AT; Camitta B; Mahoney D; Lauer SJ; Pullen DJ
Blood; 1997 Jun; 89(11):3960-6. PubMed ID: 9166833
[TBL] [Abstract][Full Text] [Related]
91. [Detection of cytoplasmic antigens by flow cytometry and its implication for leukemia immunophenotyping].
Liu YR; Yu H; Chang Y; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):17-21. PubMed ID: 12513830
[TBL] [Abstract][Full Text] [Related]
92. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia.
Lacombe F; Durrieu F; Briais A; Dumain P; Belloc F; Bascans E; Reiffers J; Boisseau MR; Bernard P
Leukemia; 1997 Nov; 11(11):1878-86. PubMed ID: 9369421
[TBL] [Abstract][Full Text] [Related]
93. CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
Gong S; Osei ES; Kaplan D; Chen YH; Meyerson H
Int J Clin Exp Pathol; 2015; 8(2):1613-21. PubMed ID: 25973046
[TBL] [Abstract][Full Text] [Related]
94. [Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia].
Quijano SM; Torres MM; Vásquez LE; Cuéllar GE; Romero ML; Martín EL; Linares A; Castaño S; Sarmiento IC; Cabrera E; Uribe GI; Andrade RE; Saavedra CE
Biomedica; 2013; 33(3):468-86. PubMed ID: 24652183
[TBL] [Abstract][Full Text] [Related]
95. Comparative study of expressions of cytoplasmic CD79a and other B-lymphoid immunomarkers in acute leukemic cells.
Zhang JY; Lü T; Yang JC; Pan L; Luo JM; Yang L; Yao L; Dong ZR; Xu SR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):954-8. PubMed ID: 16403258
[TBL] [Abstract][Full Text] [Related]
96. Immunophenotype of normal and leukemic bone marrow B-precursors in a Brazilian population. A comparative analysis by quantitative fluorescence cytometry.
Rego EM; Garcia AB; Carneiro JJ; Falcão RP
Braz J Med Biol Res; 2001 Feb; 34(2):183-94. PubMed ID: 11175493
[TBL] [Abstract][Full Text] [Related]
97. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig WD
Ann Hematol; 1998 Sep; 77(3):107-14. PubMed ID: 9797079
[TBL] [Abstract][Full Text] [Related]
98. Immunophenotypic aberrancy in adult acute lymphoblastic leukemia.
Ross CW; Stoolman LM; Schnitzer B; Schlegelmilch JA; Hanson CA
Am J Clin Pathol; 1990 Nov; 94(5):590-9. PubMed ID: 2239822
[TBL] [Abstract][Full Text] [Related]
99. Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse.
Imataki O; Ohnishi H; Yamaoka G; Arai T; Kitanaka A; Kubota Y; Kushida Y; Ishida T; Tanaka T
Int J Clin Oncol; 2010 Feb; 15(1):112-5. PubMed ID: 20066454
[TBL] [Abstract][Full Text] [Related]
100. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
Xia M; Zhang H; Lu Z; Gao Y; Liao X; Li H
J Pediatr Hematol Oncol; 2016 Aug; 38(6):418-22. PubMed ID: 27438018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]